The Clinical Waste Discussion Forum has previously reported companies offering needlestick insurance, and in Australia at least one provider continues to offer this product.
Acquiring Hepatitis B, Hepatitis C or HIV can result in many additional and unexpected care-related costs which must be a serious consideration in countries where a reliable state-funded health service is unavailable.
I wonder what the underwriters do with their profits? Perhaps they invest in and support investment in infection prevention. But perhaps not.